The AMA passed a resolution to increase access to anti-obesity medications at its annual House of Delegates meeting.The resolution was championed by the Endocrine Society, according to a press release ...

In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize ...

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

Are meal replacement drinks about weight loss, replacing breakfast, or embracing a new world of personalized smart food?

A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...

May 22 (Reuters) - Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's (NOVOb.CO), opens new tab Ozempic may modestly reduce the risk of obesity-related cancers, especially ...

But the pause brought renewed attention to one of the biggest challenges in health care today, one that played a role in GIC’s woes: the high price of popular GLP-1 drugs to treat obesity.

This story mentions weight, weight loss, and/or prescription GLP-1 drugs, which are FDA-approved ... Discover new workout ideas, healthy-eating recipes, makeup looks, skin-care advice, the best ...

In February 2022, the 46-year-old from New Jersey had prediabetes and high blood pressure when his doctor asked if he had considered trying a GLP-1 medication. She prescribed him Wegovy ...